Biosensors

Biosensors: Credit Suisse notes shares are down 7.5% since announcement of CITIC PE's stake sale, believes the over -correction represents a Buy opportunity. The buyer was not disclosed, but the house believes it is a related party who will work with CITIC in the potential privatisation - which is still a most likely scenario for Biosensors. CS upgrades from neutral to Outperform, with higher TP of $1.05 (previously $1). Key risk is the uncertain timeline of execution of a potential privatisation.